| Study |
Reference |
|
Bar-Oz - Itraconazole, 2000
|
Bar-Oz B Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study. Am J Obstet Gynecol 2000;183:617-20
|
|
Berard - Fluconazole, 2019
|
Berard Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies. CMAJ 2019; 191:E179-E187
|
|
Carter - Miconazole, 2008
|
Carter Antifungal drugs and the risk of selected birth defects. Am. J. Obstet. Gynecol. 2008; 198:191.e1-7
|
|
De Santis - Itraconazole, 2009
|
De Santis First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy. Drug Saf 2009; 32:239-44
|
|
Howley - Fluconazole, 2016
|
Howley Fluconazole use and birth defects in the National Birth Defects Prevention Study. Am. J. Obstet. Gynecol. 2016; 214:657.e1-9
|
|
Inman - Fluconazole, 1994
|
Inman Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy. Eur J Clin Pharmacol 1994; 46:115-8
|
|
Jick - Fluconazole and Itraconazole (Oral), 1999
|
Jick Pregnancy outcomes after maternal exposure to fluconazole. Pharmacotherapy 1999; 19:221-2
|
|
Kazy - Ketoconazole, 2005
|
Kazy Population-based case-control study of oral ketoconazole treatment for birth outcomes. Congenit Anom (Kyoto) 2005; 45:5-8
|
|
Kerr - Miconazole, 2018
|
Kerr Risk factors for congenital microcephaly in the pre-Zika era. Birth Defects Res 2019; 111:96-118
|
|
Mastroiacovo - Fluconazole, 1996
|
Mastroiacovo Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole. Am. J. Obstet. Gynecol. 1996; 175:1645-50
|
|
Molgaard-Nielsen - Fluconazole, 2013
|
Molgaard-Nielsen Use of oral fluconazole during pregnancy and the risk of birth defects. N. Engl. J. Med. 2013; 369:830-9
|
|
Molgaard-Nielsen - Fluconazole (Oral) (Controls exposed to pivmecillinam), 2016
|
Molgaard-Nielsen Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. JAMA 2016; 315:58-67
|
|
Molgaard-Nielsen - Fluconazole (Oral) (Controls unexposed, NOS), 2016
|
Molgaard-Nielsen Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. JAMA 2016; 315:58-67
|
|
Norgaard - Fluconazole, 2008
|
Norgaard Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. J. Antimicrob. Chemother. 2008; 62:172-6
|
|
Pasternak - Fluconazole, 2018
|
Pasternak Oral Fluconazole in Pregnancy and Risk of Stillbirth and Neonatal Death. JAMA 2018; 319:2333-2335
|
|
Rosa - Miconazole, 1987
|
Rosa Pregnancy outcomes after first-trimester vaginitis drug therapy. Obstet Gynecol 1987; 69:751-5
|
|
Ross - Miconazole, 2003
|
Ross Prescription medication use during pregnancy and risk of infant leukemia (United States). Cancer Causes Control 2003; 14:447-51
|
|
Santos - Fluconazole, 2011
|
Santos Exposure to anti-infective drugs during pregnancy and the risk of small-for-gestational-age newborns: a case-control study. BJOG 2011; 118:1374-82
|
|
Sorensen - Fluconazole, 1999
|
Sorensen Risk of malformations and other outcomes in children exposed to fluconazole in utero. Br J Clin Pharmacol 1999; 48:234-8
|
|
Zhu - Fluconazole, 2020
|
Zhu Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study. BMJ 2020; 369:m1494
|
